Literature DB >> 22001212

Multimodal treatment for multistation mediastinal lymph node adenocarcinoma: a case report.

Tomoyuki Nakano1, Shunsuke Endo, Tetsuya Endo, Tsuyoshi Hasegawa, Masayuki Nakayama, Yukihiko Sugiyama, Mitsugu Hironaka.   

Abstract

We report on a 68-year-old male with a multistation mediastinal lymph node adenocarcinoma, who had no primary lesions occurring within 48 months. After diagnosis by lymph node biopsy via right-sided thoracoscopy, the bilateral mediastinal lymphadenopathy responded to platinum-based chemotherapy. At 30 months after completion of chemotherapy, left mediastinal lymphadenopathy recurred. Left anterior mediastinal dissection via left-sided thoracoscopy was successful. After surgery, the patient did well with no primary lesions for more than a year. The etiology of mediastinal lymph node carcinoma of unknown origin is discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22001212     DOI: 10.5761/atcs.cr.11.01668

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  3 in total

1.  Primary mediastinal adenocarcinoma originating from a calcified nodule.

Authors:  Gang Chen; Xiaoming Qiu; Yi Liu; Yanjie Qiao; Tao Shi; Jun Chen; Qinghua Zhou
Journal:  Int J Clin Exp Med       Date:  2014-07-15

2.  Gene expression profiling and its use in adenocarcinomas of unknown primary origin: A case report.

Authors:  Ana Cebollero DE Miguel; Roberto Pazo Cid; Javier Martinez Trufero; Isabel Pajares Bernad; Lourdes Calera Urquizu; Jorge Hernando Cubero; Antonio Anton Torres
Journal:  Oncol Lett       Date:  2015-08-04       Impact factor: 2.967

3.  Relapsed cervicomediastinal lymph node carcinoma with an unknown primary site treated with TS-1 alone: a case report.

Authors:  Toshiki Yajima; Ryoichi Onozato; Yoshinori Shitara; Akira Mogi; Shigebumi Tanaka; Hiroyuki Kuwano
Journal:  BMC Res Notes       Date:  2013-12-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.